NC
UPB

nVerses Capital’s Upstream Bio Inc UPB Stock Holding History

nVerses Capital’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
+24,029
New +$201K 0.26% 207

Other funds holding UPB

SAM
SEB Asset Management Stockholm $26.6B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

nVerses Capital's UPB Position: Q2 2026 in Review

nVerses Capital opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 24,029 shares worth $166K. The stake represents 0.26% of the portfolio and ranks #207 among its holdings.

20 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • nVerses Capital held 24,029 shares of Upstream Bio Inc worth $166K as of Q2 2026.
  • Upstream Bio Inc was a new nVerses Capital position in Q2 2026.
  • Upstream Bio Inc made up 0.26% of nVerses Capital's portfolio in Q2 2026, its #207 holding.
  • 20 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.